Skip to main content

Cellulite

2
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Caliway Biopharmaceuticals
Caliway BiopharmaceuticalsTaiwan - New Taipei City
2 programs
2
40 mg CBL-514Phase 21 trial
CBL-514 injectionPhase 21 trial
Active Trials
NCT05632926Completed12Est. May 2023
NCT05836779Completed23Est. Jan 2024
Galderma
GaldermaTX - Dallas
2 programs
Sculptra AestheticN/A1 trial
Sculptra new dilutionN/A1 trial
Active Trials
NCT04830722Unknown20Est. Jun 2022
NCT05064761Completed29Est. Feb 2023
Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
1 program
Sculptra AestheticN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Caliway BiopharmaceuticalsCBL-514 injection
Caliway Biopharmaceuticals40 mg CBL-514
GaldermaSculptra new dilution
GaldermaSculptra Aesthetic

Clinical Trials (4)

Total enrollment: 84 patients across 4 trials

A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)

Start: May 2023Est. completion: Jan 202423 patients
Phase 2Completed

A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)

Start: Jan 2023Est. completion: May 202312 patients
Phase 2Completed
NCT05064761GaldermaSculptra new dilution

Safety and Effectiveness of Poly-l-lactic Acid (PLLA) for the Improvement in Appearance of Cellulite

Start: Nov 2021Est. completion: Feb 202329 patients
N/ACompleted
NCT04830722GaldermaSculptra Aesthetic

Clinical Trial of Poly-L-lactic Acid (Sculptra Aesthetic) for the Treatment of Cellulite of the Buttocks and Thighs

Start: Apr 2021Est. completion: Jun 202220 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.